EUVIMEDEUVIMED entdecken
Validierungsstudie

Validated LC/MS method for simultaneous determination of elbasvir and grazoprevir in human plasma

Aymen Labidi, Rafika Bensghaier, Sami Jebali, Latifa Latrous

Annales Pharmaceutiques Françaises · 2024

DOI: 10.1016/j.pharma.2024.05.006 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Annales Pharmaceutiques Françaises, 2024. Verfasst von Aymen Labidi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire National de Contrôle Des Médicaments, 11 bis, Rue Jebel Lakhdar Bab Saadoun, 1006 Tunis, Tunisia. Hauptthemen laut MEDLINE: Quinoxalines, Imidazoles, Benzofurans, Amides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A sensitive and accurate LC/MS method for the determination of elbasvir (ELB) and grazoprevir (GZP) in human plasma was established using daclatasvir (DCT) as an internal standard. The analytes were separated on a Waters Spherisorb phenyl column (150mm×4.6mm ID, 5μm particle size) maintained at 40°C±2°C. Gradient elution, at a flow rate of 0.8mLmin-1, was used. The mobile phase consists of 90% of acetonitrile mixed to 10% of a 5mM ammonium formate buffer (+0.1% v/v of trimethylamine, pH was adjusted to 3.2 by formic acid) as phase A and 10% of acetonitrile mixed to 90% of the same buffer as phase B. Liquid-liquid extraction with ethyl acetate solvent was used to recuperate compounds from plasma. The method was validated over a concentration range of 2 and 100ng/mL for GZP and between 1 and 50ng/mL for ELB. The intra- and inter-day precision and accuracy of the quality control samples at low, medium, and high concentration levels exhibited relative standard deviations (RSD)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

QuinoxalinesImidazolesBenzofuransAmidesSulfonamidesHumansReproducibility of ResultsChromatography, LiquidAntiviral AgentsCyclopropanesMass SpectrometryChromatography, High Pressure LiquidCarbamatesTandem Mass SpectrometryLimit of DetectionLactams, Macrocyclic

Stichwörter der Autor:innen

DaclatasvirElbasvirExtraction liquide–liquideGrazoprevirHuman plasmaLC/MSLiquid–liquid extractionPharmacocinétiquePharmacokineticsPlasma humain

Substanzen

QuinoxalineselbasvirImidazolesgrazoprevirBenzofuransAmidesSulfonamidesAntiviral AgentsCyclopropanesCarbamates

Autor:innen und Institutionen

  • Laboratoire National de Contrôle Des Médicaments, 11 bis, Rue Jebel Lakhdar Bab Saadoun, 1006 Tunis, Tunisia.
  • Laboratoire de Chimie Minérale Appliquée (LR19ES02), Faculté Des Sciences de Tunis, Université de Tunis El Manar, Campus Universitaire Farhat HACHED, 2092 Tunis, Tunisia; Laboratoire des Matériaux Composites et des Miné…
  • Institut National de Recherche et d'Analyse Physico-chimique, Laboratoire Matériaux Traitement et Analyse (LMTA), Biotechpole Sidi-Thabet, Ariana, Tunisia.
  • Laboratoire de Chimie Minérale Appliquée (LR19ES02), Faculté Des Sciences de Tunis, Université de Tunis El Manar, Campus Universitaire Farhat HACHED, 2092 Tunis, Tunisia; Institut Préparatoire Aux Études D'Ingénieurs El…

Zitieren

APA

Labidi, A., Bensghaier, R., Jebali, S., & Latrous, L. (2024). Validated LC/MS method for simultaneous determination of elbasvir and grazoprevir in human plasma. Annales Pharmaceutiques Françaises. https://doi.org/10.1016/j.pharma.2024.05.006

Vancouver

Labidi A, Bensghaier R, Jebali S, Latrous L. Validated LC/MS method for simultaneous determination of elbasvir and grazoprevir in human plasma. Annales Pharmaceutiques Françaises. 2024. doi:10.1016/j.pharma.2024.05.006

BibTeX
@article{Labidi2024,
  author = {Labidi, Aymen and Bensghaier, Rafika and Jebali, Sami and Latrous, Latifa},
  title = {Validated LC/MS method for simultaneous determination of elbasvir and grazoprevir in human plasma},
  journal = {Annales Pharmaceutiques Françaises},
  year = {2024},
  doi = {10.1016/j.pharma.2024.05.006}
}
Kostenlos starten →